Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Xin Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5154-2115; OpenAlex author ID A5100353686. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers

Papers 4

  1. Targeted intervention in nerve-cancer crosstalk enhances pancreatic cancer chemotherapy. Co-author DOI 10.1038/s41565-024-01803-1↗
  2. Causal relationships between immunophenotypes, plasma metabolites, and pancreatic cancer: a mediation Mendelian randomization study. Co-author DOI 10.1093/jleuko/qiaf120↗
  3. Utility of Dark-Blood Dual-Energy CT Images for Predicting Vascular Involvement and R0 Resection in Patients With Pancreatic Cancer. Last author DOI 10.2214/ajr.22.28640↗
  4. microRNA-based autophagy inhibition as targeted therapy in pancreatic cancer. First author DOI 10.1016/j.biopha.2020.110799↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiubao Ren · 1 shared paper, 2025 · strength 0.30
  2. Jiawei Liu · 1 shared paper, 2025 · strength 0.30
  3. Lu Gan · 1 shared paper, 2025 · strength 0.21
  4. Gao‐Jun Teng · 1 shared paper, 2025 · strength 0.21
  5. Shanmiao Gou · 1 shared paper, 2025 · strength 0.21
  6. Ben Zhao · 1 shared paper, 2025 · strength 0.21
  7. Jiaqi Qin · 1 shared paper, 2025 · strength 0.21
  8. Shenghong Ju · 1 shared paper, 2025 · strength 0.21
  9. Keke Si · 1 shared paper, 2023 · strength 0.18
  10. Jun Xue · 1 shared paper, 2023 · strength 0.18
  11. Ping Han · 1 shared paper, 2023 · strength 0.18
  12. Heshui Wu · 1 shared paper, 2023 · strength 0.18
  13. Sanhong Liang · 1 shared paper, 2020 · strength 0.16
  14. Lexing Zhang · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.